NYSE:ELAN | Free Cash Flow | Elanco Animal Health Inc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$13M$51M-$38M-66.67%
2025-12-31$108M$62M$46M
2025-03-31-$4M$65M-$69M-102.99%
2024-12-31$177M$47M$130M
2024-03-31$2M$24M-$22M-68.75%
2023-12-31$157M$41M$116M
2023-03-31-$145M$24M-$169M-164.08%
2022-12-31$13M$100M-$87M
2022-03-31-$62M$19M-$81M-158.82%
2021-12-31$223M$99M$124M
2021-03-31$22M$18M$4M
2020-12-31-$93M$119M-$212M
2020-03-31$4M$13M-$9M
2019-12-31$126.2M$90.2M$36M
2019-03-31$8.1M$28M-$19.9M-63.17%
2018-12-31$139.5M$60.2M$79.3M483.54%
2018-03-31$47M$32.7M$14.3M19.67%
2017-12-31$6.7M$66.9M-$60.2M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$560M$276M$284M
2024-12-31$541M$147M$394M116.57%
2023-12-31$271M$140M$131M
2022-12-31$452M$171M$281M
2021-12-31$483M$159M$324M
2020-12-31-$41M$135M-$176M
2019-12-31$224M$140M$84M123.53%
2018-12-31$487.3M$134.5M$352.8M407.86%
2017-12-31$173.8M$98.6M$75.2M
2016-12-31$155.9M$110.3M$45.6M